Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
A Pharmacokinetic and Pharmacodynamic Study Comparing HLX01 And Rituximab in Patients With CD20-Positive, B-cell Lymphoma
ClinicalTrials.gov study NCT02584920. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Pembrolizumab for Patients With PD-L1 Diffuse Large B Cell Lymphoma (DLBCL)
ClinicalTrials.gov study NCT03990961. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Clinical Trial on Hepatitis B Vaccine Activated-Dendritic Cells Combined With Anti-HBV Drugs in CHB
ClinicalTrials.gov study NCT02615639. IPD Sharing: Not stated. Countries: 0. Publications: 2.
Phase I/II Trial of R-CHOP + Azacytidine in Diffuse Large B Cell Lymphoma
ClinicalTrials.gov study NCT01004991. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Antitumor Activity Study of Loncastuximab Tesirine and Durvalumab in Diffuse Large B-Cell, Mantle Cell, or Follicular Lymphoma
ClinicalTrials.gov study NCT03685344. IPD Sharing: NO. Countries: 2. Publications: 0.
A Phase 1, Dose-escalation Study of MEDI-551 in Japanese Adult Patients With Relapsed or Refractory Advanced B-cell Malignancies
ClinicalTrials.gov study NCT01957579. IPD Sharing: Not stated. Countries: 1. Publications: 0.
YY-20394 、GEMOX Treatment Diffuse Large B-cell Lymphoma Single Arm, Open, Multicentrized Phase 1b/2 Clinical Trial
ClinicalTrials.gov study NCT04500561. IPD Sharing: NO. Countries: 0. Publications: 1.
Chemotherapy, Radiation Therapy, Rituximab, and Umbilical Cord Blood Transplant in Treating Patients With B-Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00387959. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Rituximab and GM-CSF in Treating Patients With Newly Diagnosed Follicular B-Cell Lymphoma
ClinicalTrials.gov study NCT00411086. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Orelabrutinib in Combination With R2 Regimen for R/R CD20+ B-cell Lymphoma
ClinicalTrials.gov study NCT05014100. IPD Sharing: NO. Countries: 0. Publications: 4.
A Study to Evaluate the Safety and Efficacy of JCAR017 in Pediatric Subjects With Relapsed/Refractory (r/r) B-cell Acute Lymphoblastic Leukemia (B-ALL) and B-cell Non-Hodgkin Lymphoma (B-NHL)
ClinicalTrials.gov study NCT03743246. IPD Sharing: Not stated. Countries: 6. Publications: 0.
Study to Learn if 200mg Test Drug (Fostamatinib) Helps People With Large B-Cell Lymphoma,a Type of Blood Cancer
ClinicalTrials.gov study NCT01499303. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lymphomas
ClinicalTrials.gov study NCT03038672. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Tolerability Study of MEDI-551, a B-cell Depleting Agent, to Treat Relapsing Forms of Multiple Sclerosis
ClinicalTrials.gov study NCT01585766. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Phase II Trial of Alemtuzumab (Campath) and Dose-Adjusted EPOCH-Rituximab (DA-EPOCH-R) in Relapsed or Refractory Diffuse Large B-Cell and Hodgkin Lymphomas
ClinicalTrials.gov study NCT01030900. IPD Sharing: YES. Countries: 1. Publications: 0.
Study of Mocetinostat in Selected Patients With Mutations of Acetyltransferase Genes in Relapsed and Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma
ClinicalTrials.gov study NCT02282358. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas
ClinicalTrials.gov study NCT05685173. IPD Sharing: YES. Countries: 5. Publications: 0.
A Study of Durvalumab in Combination With R-CHOP or Lenalidomide Plus R-CHOP in Previously Untreated High-Risk Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT03003520. IPD Sharing: Not stated. Countries: 5. Publications: 0.
Phase 0/1 Biomarker and Pharmacodynamic Study of Roflumilast in Patients With Advanced B-Cell Hematologic Malignancies (CTRC# 13-0013)
ClinicalTrials.gov study NCT01888952. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Dose Escalation, Expansion Study of Vofatamab (B-701) in Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma
ClinicalTrials.gov study NCT02401542. IPD Sharing: NO. Countries: 9. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.